0
Research Letters |

Temporal Trends in Ischemic Stroke and Anticoagulation Therapy Among Medicare Patients With Atrial Fibrillation:  A 15-Year Perspective (1992-2007)

Gautam R. Shroff, MBBS; Craig A. Solid, PhD; Charles A. Herzog, MD
JAMA Intern Med. 2013;173(2):159-160. doi:10.1001/jamainternmed.2013.1579.
Text Size: A A A
Published online

Extract

Atrial fibrillation (AF) is an independent, modifiable risk factor for ischemic stroke1 and independently associated with increased mortality.2 Nonvalvular AF is associated with a nearly 5-fold higher risk of ischemic stroke; this risk progressively increases with age.3 In a meta-analysis involving 29 clinical studies and 28 044 patients, judicious antithrombotic therapy with adjusted-dose warfarin was shown to reduce risk related to ischemic stroke by nearly 60% and mortality by approximately 25%, without significant increases in hemorrhagic stroke.4 However, diffusion of evidence-based knowledge from clinical trials into routine clinical practice demonstrates a significant time lag and evidence-to-practice gap; rates of ischemic stroke are therefore higher in clinical practice.5 We sought to extend previous work by Lakshminarayan et al6 to examine temporal trends in ischemic and hemorrhagic stroke rates and warfarin use in the Medicare population over a span of 15 years.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure. Trends in ischemic and hemorrhagic stroke rates and warfarin use among patients with prevalent atrial fibrillation.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment
Are the stroke rates age- and sex-adjusted?
Posted on January 3, 2013
Alvaro Alonso
Division of Epidemiology and Community Health, University of Minnesota, Minneapolis
Conflict of Interest: None Declared
This research letter shows that among fee-for-service (FFS) Medicare enrollees with atrial fibrillation, there has been a decrease in stroke rates in parallel with an increase of warfarin use. In the discussion, the authors recognize the study limitations. One issue the authors did not clarify, however, was whether the age-specific stroke rates and warfarin use prevalence were standardized by age, sex, and race. As Piccini et al have recently shown (Piccini J, et al. Circ Cardiovasc Qual Outcomes 2012;5:85-93, PMID: 22235070), AF prevalence among FFS Medicare enrollees has increased over time, particularly among the elderly. Therefore, comparing rates in the early 90s with those in the 2000s might not make sense due to the differences in age distribution of AF patients. To be able to interpret these results appropriately, the authors should provide sociodemographic information on AF patients over time and report standardized rates, in addition or instead of crude rates. If the rates presented in the study are already standardized, that should be made clear.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com